Celine Halioua, CEO and founder of Loyal, explores groundbreaking ways to extend dog lifespans through innovative drug developments. With her background in neuroscience, she discusses the benefits of canine-specific medications and the parallels between dog and human aging. The episode delves into the challenges of developing effective treatments while addressing genetic issues stemming from selective breeding. Celine also shares insights on the ethics of veterinary research and the critical role of continued advancements in pet health for overall well-being.

Celine Halioua, CEO of Loyal, discusses developing longevity drugs for dogs and potentially humans. Topics include FDA approval process, differences between biotech and software startups, mistakes as a founder, growth rate in hiring, and starting with dogs for drug development.

Celine Halioua, CEO and founder of Loyal, is on a mission to extend the lives of our furry companions with groundbreaking biopharmaceuticals. The discussion dives into her innovative drug, LOY-1, which slows aging in large dog breeds and hints at possible benefits for humans. Celine shares insights on the intriguing link between dog size and lifespan, along with the ethical dynamics of life extension. Plus, she sheds light on the unique challenges her biotech company faces in the pet health market.

Celine Halioua, Founder/CEO of Loyal, announced FDA approval for a drug that can extend lifespan, a groundbreaking milestone in longevity biotech. The podcast explores the pursuit of immortality, targeting root causes of aging, challenges in aging research, and a young female founder's experience in the biotech industry.

Top Silicon Valley entrepreneurs discuss life extension. James Peyer acquires majority stakes in drugs for broader use. Celine Halioua develops drugs to make dogs live longer. They explore pharmacological interventions, different categories of innovations, and the impact of influential individuals like Brian Johnson. The podcast also highlights personal health experimentation and evidence-based practices for maximizing health.